ES2192588T3 - 4-(arilaminometilen)-2,4-dihidro-pirazol-3-onas. - Google Patents
4-(arilaminometilen)-2,4-dihidro-pirazol-3-onas.Info
- Publication number
- ES2192588T3 ES2192588T3 ES96107518T ES96107518T ES2192588T3 ES 2192588 T3 ES2192588 T3 ES 2192588T3 ES 96107518 T ES96107518 T ES 96107518T ES 96107518 T ES96107518 T ES 96107518T ES 2192588 T3 ES2192588 T3 ES 2192588T3
- Authority
- ES
- Spain
- Prior art keywords
- sup
- sub
- rent
- atomos
- replaced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- -1 AMINO Chemical class 0.000 abstract 4
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical group ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 abstract 2
- 229910052801 chlorine Chemical group 0.000 abstract 2
- 239000000460 chlorine Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical class O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 abstract 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 abstract 1
- 229940124639 Selective inhibitor Drugs 0.000 abstract 1
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical class O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical group [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Inks, Pencil-Leads, Or Crayons (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Photoreceptors In Electrophotography (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
LA INVENCION TRATA DE DERIVADOS DE LA DL 2 PIRAZOLINONA-5 DE FORMULA GENERAL I: EN DONDE R{SUP,1} ES BENZILO, ALCOXIBENZILO CON 1 - 3 ATOMOS DE C EN LA PARTE ALQUILICA, FENILO, FENILO SUSTITUIDO DE UNA A TRES VECES CON AMINO, ACILO, HALOGENO, NITRO, CN, AO-, CARBOXILO, SULFONILO, A-O-CO-, A-CO-NH-, A-CO-NA-, CARBAMOILO, N-ALQUILCARBAMOILO, N,NDIALQUILCARBAMOILO (CON 1 - 6 ATOMOS DE C EN LA PARTE ALQUILICA, A-O-CO-NH-, A-C-CO-NA-, SO{SUB,2}NR{SUP,4}R{SUP,5} (R{SUP,4} Y R{SUP,5} PUEDEN SER H O ALQUILO CON 1 - 6 ATOMOS DE C, O NR{SUP,4}R{SUP,5} UN CICLO DE 5 O 6 MIEMBROS, QUE PUEDE ESTAR SUSTITUIDO CON OTROS HETEROATOMOS COMO N, S, O O POR A) A-CO-NHSO{SUB,2}-, A-CO-NA-SO{SUB,2}-, A-SO{SUB,2}-NH-, A-SO{SUB,2}-NA-, (A-SO{SUB,2}-){SUB,2}N-, TETRAZOLILO, O FOSFONILO; O PIRIDILO; R{SUP,2} ES ALQUILO CON 1 - 5 ATOMOS DE C, ALCOXICARBONILALQUILO, HIDROXIALQUILO, HIDROXICARBONILALQUILO; R{SUP,3} ES H, ALQUILO CON 1 - 5 ATOMOS DE C DE CADENA LINEAL O RAMIFICADA, ALCOXILO CON 1- 5 ATOMOS DE C DE CADENALINEAL O RAMIFICADA; O ALQUILO, AMINOALCANOILO, AMINOALQUILO, CARBAMOILO, SO{SUB,2}NR{SUP,4}R{SUP,5} QUE PUEDEN ESTAR SUSTITUIDOS CON FLUOR O CLORO (R{SUP,4}Y R{SUP,5} PUEDEN SER H, ALQUILO CON 1 - 6 ATOMOS DE C O NR{SUP,4}R{SUP,5} FORMAR UN CICLO DE 5 O 6 MIEMBROS, QUE PUEDE ESTAR SUSTITUIDO CON OTROS HETEROATOMOS COMO N, S, O O CON A); A ES UN ALQUILO CON 1 - 6 ATOMOS DE C DE CADENA LINEAL O RAMIFICADA, O ESTE ALQUILO SUSTITUIDO CON FLUOR O CLORO; Y SUS SALES FISIOLOGICAMENTE ACEPTABLES. UNA PARTE DE LA INVENCION SON TAMBIEN LOS PROCEDIMIENTOS PARA LA OBTENCION DE ESTOS COMPUESTOS, Y SU UTILIZACION COMO INHIBIDORES SELECTIVOS DE LAS FOSFODIESTERASAS ESPECIFICAS DE LA CGMP (CGMP PDE) Y COMPUESTOS FARMACEUTICAMENTE EFECTIVOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19518082A DE19518082A1 (de) | 1995-05-17 | 1995-05-17 | 4(-Arylaminomethylen)-2,4-dihydropyrazol-3-one |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2192588T3 true ES2192588T3 (es) | 2003-10-16 |
Family
ID=7762136
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96107518T Expired - Lifetime ES2192588T3 (es) | 1995-05-17 | 1996-05-10 | 4-(arilaminometilen)-2,4-dihidro-pirazol-3-onas. |
Country Status (22)
Country | Link |
---|---|
US (1) | US5869516A (es) |
EP (1) | EP0743304B1 (es) |
JP (1) | JP3996656B2 (es) |
KR (1) | KR100413154B1 (es) |
CN (1) | CN1066138C (es) |
AT (1) | ATE235469T1 (es) |
AU (1) | AU713042B2 (es) |
CA (1) | CA2176649C (es) |
CZ (1) | CZ291572B6 (es) |
DE (2) | DE19518082A1 (es) |
DK (1) | DK0743304T3 (es) |
ES (1) | ES2192588T3 (es) |
HU (1) | HUP9601328A3 (es) |
NO (1) | NO306777B1 (es) |
PL (1) | PL186049B1 (es) |
PT (1) | PT743304E (es) |
RU (1) | RU2180659C2 (es) |
SI (1) | SI0743304T1 (es) |
SK (1) | SK284295B6 (es) |
TW (1) | TW349093B (es) |
UA (1) | UA59330C2 (es) |
ZA (1) | ZA963918B (es) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19518082A1 (de) * | 1995-05-17 | 1996-11-21 | Merck Patent Gmbh | 4(-Arylaminomethylen)-2,4-dihydropyrazol-3-one |
DE19642284A1 (de) * | 1996-10-14 | 1998-04-16 | Merck Patent Gmbh | Pyrazolinone zur Behandlung von Potenzstörungen |
US6331543B1 (en) * | 1996-11-01 | 2001-12-18 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
US5858694A (en) * | 1997-05-30 | 1999-01-12 | Cell Pathways, Inc. | Method for identifying compounds for inhibition of cancerous lesions |
CA2238283C (en) | 1997-05-30 | 2002-08-20 | Cell Pathways, Inc. | Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions |
US6410584B1 (en) | 1998-01-14 | 2002-06-25 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells with indole derivatives |
DE19807423A1 (de) | 1998-02-21 | 1999-08-26 | Hoechst Marion Roussel De Gmbh | Subustituierte Isoindolone, ihre Herstellung und ihre Verwendung in Arzneimitteln |
US6727238B2 (en) | 1998-06-11 | 2004-04-27 | Pfizer Inc. | Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
TNSN99111A1 (fr) * | 1998-06-11 | 2005-11-10 | Pfizer | Derives de sulfonylbenzene nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant. |
US6294558B1 (en) | 1999-05-31 | 2001-09-25 | Pfizer Inc. | Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
US6200771B1 (en) | 1998-10-15 | 2001-03-13 | Cell Pathways, Inc. | Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia |
US6130053A (en) * | 1999-08-03 | 2000-10-10 | Cell Pathways, Inc. | Method for selecting compounds for inhibition of neoplastic lesions |
US6133271A (en) * | 1998-11-19 | 2000-10-17 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives |
US6187779B1 (en) | 1998-11-20 | 2001-02-13 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives |
US6369092B1 (en) | 1998-11-23 | 2002-04-09 | Cell Pathways, Inc. | Method for treating neoplasia by exposure to substituted benzimidazole derivatives |
US6034099A (en) * | 1998-11-24 | 2000-03-07 | Cell Pathways, Inc. | Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones |
US6077842A (en) * | 1998-11-24 | 2000-06-20 | Cell Pathways, Inc. | Method of inhibiting neoplastic cells with pyrazolopyridylpyridazinone derivatives |
US6486155B1 (en) | 1998-11-24 | 2002-11-26 | Cell Pathways Inc | Method of inhibiting neoplastic cells with isoquinoline derivatives |
US6025394A (en) | 1999-01-29 | 2000-02-15 | Cell Pathways, Inc. | Method for treating patients with acne by administering substituted sulfonyl indenyl acetic acids, amides and alcohols |
US6020379A (en) * | 1999-02-19 | 2000-02-01 | Cell Pathways, Inc. | Position 7 substituted indenyl-3-acetic acid derivatives and amides thereof for the treatment of neoplasia |
US6555547B1 (en) | 2000-02-28 | 2003-04-29 | Cell Pathways, Inc. | Method for treating a patient with neoplasia by treatment with a vinca alkaloid derivative |
US6569638B1 (en) | 2000-03-03 | 2003-05-27 | Cell Pathways, Inc | Method for screening compounds for the treatment of neoplasia |
MXPA05011200A (es) * | 2003-04-18 | 2005-12-14 | Memory Pharm Corp | Derivados de pirazol como inhibidores de fosfodiesterasa 4. |
US7432266B2 (en) * | 2004-10-15 | 2008-10-07 | Memory Pharmaceuticals Corporation | Phosphodiesterase 4 inhibitors |
US8506934B2 (en) | 2005-04-29 | 2013-08-13 | Robert I. Henkin | Methods for detection of biological substances |
EP2258357A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
EP2275095A3 (en) | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
BRPI0606132A2 (pt) * | 2005-10-12 | 2009-06-02 | Sicor Inc | formas cristalinas de docetaxel e processos para seu preparo |
EP2377530A3 (en) | 2005-10-21 | 2012-06-20 | Braincells, Inc. | Modulation of neurogenesis by PDE inhibition |
AU2006308889A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | GABA receptor mediated modulation of neurogenesis |
EP2218442A1 (en) | 2005-11-09 | 2010-08-18 | CombinatoRx, Inc. | Methods, compositions, and kits for the treatment of ophthalmic disorders |
AU2007223036A1 (en) * | 2006-03-08 | 2007-09-13 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
US20100009983A1 (en) * | 2006-05-09 | 2010-01-14 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
EP2382975A3 (en) | 2006-05-09 | 2012-02-29 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
WO2007134077A2 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
BRPI0716604A2 (pt) * | 2006-09-08 | 2013-04-09 | Braincells Inc | combinaÇÕes contendo um derivado de 4-acilaminopiridina |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
US20080103165A1 (en) * | 2006-09-19 | 2008-05-01 | Braincells, Inc. | Ppar mediated modulation of neurogenesis |
WO2008095136A2 (en) | 2007-01-31 | 2008-08-07 | Henkin Robert I | Methods for detection of biological substances |
EP2002835A1 (en) * | 2007-06-04 | 2008-12-17 | GenKyo Tex | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
EP2000176A1 (en) * | 2007-06-04 | 2008-12-10 | GenKyo Tex | Tetrahydroindole derivatives as NADPH Oxidase inhibitors |
US8580801B2 (en) * | 2008-07-23 | 2013-11-12 | Robert I. Henkin | Phosphodiesterase inhibitor treatment |
EP2166009A1 (en) * | 2008-09-23 | 2010-03-24 | Genkyo Tex Sa | Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
EP2166010A1 (en) * | 2008-09-23 | 2010-03-24 | Genkyo Tex Sa | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
EP2166008A1 (en) | 2008-09-23 | 2010-03-24 | Genkyo Tex Sa | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
EP2165707A1 (en) * | 2008-09-23 | 2010-03-24 | Genkyo Tex Sa | Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
EP2305679A1 (en) | 2009-09-28 | 2011-04-06 | GenKyoTex SA | Pyrazoline dione derivatives as nadph oxidase inhibitors |
US20150119399A1 (en) | 2012-01-10 | 2015-04-30 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
EP2903619B1 (en) | 2012-10-05 | 2019-06-05 | Robert I. Henkin | Phosphodiesterase inhibitors for treating taste and smell disorders |
CA2937542A1 (en) | 2014-02-14 | 2015-08-20 | Inception 2, Inc. | Pyrazolone compounds and uses thereof |
US10598672B2 (en) | 2014-02-18 | 2020-03-24 | Cyrano Therapeutics, Inc. | Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell |
EP3479843A1 (en) | 2017-11-01 | 2019-05-08 | GenKyoTex Suisse SA | Use of nox inhibitors for treatment of cancer |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3905997A (en) * | 1974-06-21 | 1975-09-16 | Warner Lambert Co | 3-Aryl-5-oxo-2-pyrazoline-4-carboxanilides and process therefor |
US4355159A (en) * | 1979-05-23 | 1982-10-19 | Ciba-Geigy Corporation | Nickel complex pigments of azines |
US4666908A (en) * | 1985-04-05 | 1987-05-19 | Warner-Lambert Company | 5-Substituted pyrazolo[4,3-d]pyrimidine-7-ones and methods of use |
DK169672B1 (da) * | 1985-05-20 | 1995-01-09 | Mitsubishi Chem Ind | Farmaceutiske præparater indeholdende pyrazolonderivater som aktiv bestanddel og anvendelsen af pyrazolonderivater til fremstilling af farmaceutiske præparater |
US5162528A (en) * | 1986-12-17 | 1992-11-10 | Bayer Aktiengesellschaft | Herbicidal and fungicidal agents based on substituted pyrazolin-5-one derivatives |
DE3728278A1 (de) * | 1986-12-17 | 1988-06-23 | Bayer Ag | Herbizide und fungizide mittel auf basis von substituierten pyrazolin-5-on derivaten |
US4880804A (en) * | 1988-01-07 | 1989-11-14 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking benzimidazoles |
GB9119704D0 (en) * | 1991-09-14 | 1991-10-30 | Pfizer Ltd | Therapeutic agents |
DE4130833A1 (de) * | 1991-09-17 | 1993-03-18 | Bayer Ag | Diarylpyrazolinone |
DE19518082A1 (de) * | 1995-05-17 | 1996-11-21 | Merck Patent Gmbh | 4(-Arylaminomethylen)-2,4-dihydropyrazol-3-one |
-
1995
- 1995-05-17 DE DE19518082A patent/DE19518082A1/de not_active Withdrawn
-
1996
- 1996-03-18 TW TW085103221A patent/TW349093B/zh active
- 1996-05-09 SK SK589-96A patent/SK284295B6/sk unknown
- 1996-05-10 ES ES96107518T patent/ES2192588T3/es not_active Expired - Lifetime
- 1996-05-10 DK DK96107518T patent/DK0743304T3/da active
- 1996-05-10 PT PT96107518T patent/PT743304E/pt unknown
- 1996-05-10 AT AT96107518T patent/ATE235469T1/de not_active IP Right Cessation
- 1996-05-10 DE DE59610254T patent/DE59610254D1/de not_active Expired - Lifetime
- 1996-05-10 SI SI9630609T patent/SI0743304T1/xx unknown
- 1996-05-10 EP EP96107518A patent/EP0743304B1/de not_active Expired - Lifetime
- 1996-05-13 AU AU52253/96A patent/AU713042B2/en not_active Ceased
- 1996-05-13 UA UA96051861A patent/UA59330C2/uk unknown
- 1996-05-15 CA CA002176649A patent/CA2176649C/en not_active Expired - Fee Related
- 1996-05-15 CN CN96107453A patent/CN1066138C/zh not_active Expired - Fee Related
- 1996-05-15 NO NO961996A patent/NO306777B1/no not_active IP Right Cessation
- 1996-05-16 CZ CZ19961421A patent/CZ291572B6/cs not_active IP Right Cessation
- 1996-05-16 RU RU96109192/04A patent/RU2180659C2/ru not_active IP Right Cessation
- 1996-05-16 PL PL96314286A patent/PL186049B1/pl not_active IP Right Cessation
- 1996-05-16 US US08/648,951 patent/US5869516A/en not_active Expired - Lifetime
- 1996-05-16 HU HU9601328A patent/HUP9601328A3/hu unknown
- 1996-05-16 KR KR1019960016421A patent/KR100413154B1/ko not_active IP Right Cessation
- 1996-05-16 ZA ZA963918A patent/ZA963918B/xx unknown
- 1996-05-17 JP JP14644696A patent/JP3996656B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
PL186049B1 (pl) | 2003-09-30 |
ATE235469T1 (de) | 2003-04-15 |
EP0743304A1 (de) | 1996-11-20 |
UA59330C2 (uk) | 2003-09-15 |
JP3996656B2 (ja) | 2007-10-24 |
HUP9601328A2 (en) | 1997-02-28 |
RU2180659C2 (ru) | 2002-03-20 |
PL314286A1 (en) | 1996-11-25 |
SI0743304T1 (en) | 2003-10-31 |
CZ142196A3 (en) | 1997-01-15 |
JPH08311035A (ja) | 1996-11-26 |
TW349093B (en) | 1999-01-01 |
DE19518082A1 (de) | 1996-11-21 |
SK284295B6 (sk) | 2005-01-03 |
AU713042B2 (en) | 1999-11-25 |
PT743304E (pt) | 2003-08-29 |
NO961996D0 (no) | 1996-05-15 |
NO961996L (no) | 1996-11-18 |
CN1066138C (zh) | 2001-05-23 |
HUP9601328A3 (en) | 1999-04-28 |
NO306777B1 (no) | 1999-12-20 |
DK0743304T3 (da) | 2003-07-14 |
KR100413154B1 (ko) | 2004-05-12 |
ZA963918B (en) | 1996-11-25 |
KR960041166A (ko) | 1996-12-19 |
AU5225396A (en) | 1996-11-28 |
CA2176649A1 (en) | 1996-11-18 |
EP0743304B1 (de) | 2003-03-26 |
CZ291572B6 (cs) | 2003-04-16 |
DE59610254D1 (de) | 2003-04-30 |
CA2176649C (en) | 2008-08-05 |
CN1141291A (zh) | 1997-01-29 |
HU9601328D0 (en) | 1996-07-29 |
US5869516A (en) | 1999-02-09 |
SK58996A3 (en) | 1996-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2192588T3 (es) | 4-(arilaminometilen)-2,4-dihidro-pirazol-3-onas. | |
CO4930259A1 (es) | Derivados 6,6-heterobiciclicos sustituidos y composiciones farmaceuticas que los contienen | |
ES2053609T3 (es) | Derivados de urea inhibidores de lipoxigenasa. | |
ECSP055747A (es) | Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos | |
ES2053451T3 (es) | Un procedimiento para la preparacion de un compuesto que tiene propiedades farmacologicas utiles. | |
UY28040A1 (es) | Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos. | |
ES2161290T3 (es) | Derivados de quinazolina. | |
UY26512A1 (es) | Inhibidores no peptídicos de la unión celúlar dependiente de vla - 4 útiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias | |
ES2054860T5 (es) | Derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion y su utilizacion como medicamentos. | |
NO2013019I1 (no) | Kombinasjon omfattende aliskiren, som den frie basen eller som et farmasøytisk akseptabelt salt derav, og hydroklortiazid eller et farmasøytisk akseptabelt salt derav. | |
ECSP034917A (es) | Nuevos derivados de acido sulfonico | |
FI940192A0 (fi) | 2-(4-hydroksipiperidino)-1-alkonolijohdannaisia verettömyyden vastaisina aineina | |
ES2183332T3 (es) | Aminoacidos biciclicos aromaticos. | |
ES2118203T3 (es) | Nuevos derivados benzopiranicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
ES2067874T3 (es) | Derivados de acetamida. | |
PT97395A (pt) | Processo para a preparacao de 2,9-di-substituidas-4h-pirido{1,2-a}-pirimidin-4-onas e de composicoes farmaceuticas que os contem | |
ES2147427T3 (es) | Aminas ciclicas n-sustituidas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen. | |
AR029343A1 (es) | USO DE UN ANTAGONISTA DE NMDA DE BAJA AFINIDAD PARA EL TRATAMIENTO DE LA DEPRESIoN | |
MX9205123A (es) | Derivados de 5-hidroxi-2-pirimidinilmetileno utiles como agentes anti-inflamatorios. | |
AR041339A1 (es) | Derivados de tiazolpirimidinona,proceso de preparacion y composiciones farmaceuticas que los contienen | |
PT91435A (pt) | Processo para a preparacao de aril-alquil-aminas e -amidas possuindo propriedades anticonvulsivas e neuroprotectoras e de composicoes farmaceuticas que as contem | |
ES2052593T3 (es) | Procedimiento para preparar derivados del indano. | |
AR026350A1 (es) | Derivados de isoxazol como inhibidores de la fosfodiesterasa vii | |
ES2029879T3 (es) | Procedimiento para producir derivados de aminas sustituidas. | |
UY27034A1 (es) | Derivados de pirimidina |